California

Sofinnova Investments

Sofinnova Investments, based in California, backs life sciences companies at Series A and Series B, can lead rounds with $10M to $30M checks, and has notable investments like Natera and Seattle Genetics.

Entry stageSeries A, Series B
Check size$10M to $30M
Leads roundsYes
FocusLife sciences
Latest fund$4.6B$4.6B AUM and committed capital
Investing team10 peopleNo activity since Sep

Who you would pitch at Sofinnova Investments

10 people on the investing team, 7 of them partners who can make the call. Partners are listed first.

Work here and something is wrong? Ask for a correction.

Writes $10M to $30M checks. Its smallest check is larger than 97% of firms in the atlas.

Bars: how many firms in the atlas report each band. Highlighted: this firm.

No recent activity since September 2026. Quiet does not mean closed.

Weekly count of activity updates. Activity is not a confirmed deal.

Before you pitch

Ownership target7-10%
How to reach them[email protected]

Notable investments

NateraSeattle GeneticsAmarinAerie PharmaceuticalsRapport TherapeuticsBioAge LabsArriVent

In their words

Home | SofinnovaSofinnova deploys human and financial capital to turn dreams into drugs. We are a clinical-stage biopharmaceutical venture capital firm with approximately $2B in assets uwww.sofinnova.com
Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Alert me when Sofinnova Investments is active

One email when this firm shows new activity. Nothing else.

Firms like Sofinnova Investments

On these lists

Questions

What stage does Sofinnova Investments invest in?

Sofinnova Investments reports entry at series a, series b.

How much does Sofinnova Investments invest?

Sofinnova Investments reports checks of $10M to $30M.

Does Sofinnova Investments lead rounds?

Yes. Sofinnova Investments says it can lead.

Who are the partners at Sofinnova Investments?

Jim Healy (Managing Partner), Maha Katabi (General Partner), Chris Carpenter (Executive Partner, Private Equity), Jakob Dupont (Executive Partner, Private Equity), Jonathan Leff (Executive Partner, Private Equity), Lars Ekman (Executive Partner, Private Equity).

Is Sofinnova Investments active right now?

No recent activity since September 2026.

Work at Sofinnova Investments? Claim or correct this profile.